InvestorsHub Logo
Followers 25
Posts 1336
Boards Moderated 0
Alias Born 11/15/2016

Re: None

Thursday, 01/26/2017 7:57:49 PM

Thursday, January 26, 2017 7:57:49 PM

Post# of 203912
8-k , She has experience with FDA read below!

Shefa Amirim provides clients with the requisite regulatory plans, designing and conducting the required clinical studies, CRO services and the preparation of technical files and and related services necessary for FDA applications and approval.

Now, think bigger then our psoriasis Cream...

The company stated recently, "We will submitt an application with the FDA for an orphan disease application for multiple Myeloma."

This could becoming up sooner then we think with Shefa coming on board!

Now look at for example GWPH's stock once they got close too orphan disease approval last March, April time frame of there epilepsy drug. It about doubled from about $20.00 to $40.00 and the rest was history.

Im not sure when, but someday soon this stock will gap up and never look back! IMO